79626 Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 

practices regulation (21 CFR 10.115). 

The guidance represents the current 

thinking of FDA on ‘‘Clarification of 

Radiation Control Regulations for 

Manufacturers of Diagnostic X-Ray 

Equipment.’’ It does not establish any 

rights for any person and is not binding 

on FDA or the public. You can use an 

alternative approach if it satisfies the 

requirements of the applicable statutes 

and regulations. 

II. Electronic Access 

Persons interested in obtaining a copy 

of the guidance may do so by 

downloading an electronic copy from 

the internet. A search capability for all 

Center for Devices and Radiological 

Health guidance documents is available 

at https://www.fda.gov/medical-devices/ 

device-advice-comprehensiveregulatory-assistance/guidancedocuments-medical-devices-andradiation-emitting-products. This 

guidance document is also available at 

https://www.regulations.gov or https://

www.fda.gov/regulatory-information/ 

search-fda-guidance-documents. 

Persons unable to download an 

electronic copy of ‘‘Clarification of 

Radiation Control Regulations for 

Manufacturers of Diagnostic X-Ray 

Equipment’’ may send an email request 

to CDRH-Guidance@fda.hhs.gov to 

receive an electronic copy of the 

document. Please use the document 

number GUI01500029 and complete 

title to identify the guidance you are 

requesting. 

III. Paperwork Reduction Act of 1995 

While this guidance contains no new 

collection of information, it does refer to 

previously approved FDA collections of 

information. The previously approved 

collections of information are subject to 

review by the Office of Management and 

Budget (OMB) under the Paperwork 

Reduction Act of 1995 (PRA) (44 U.S.C. 

3501–3521). The collections of 

information in the following FDA table 

have been approved by OMB: 

21 CFR Part or FDA Form Topic OMB Control No. 

1002, 1005, 1010, 1020, 1030, 1040, and 1050; form FDA 

2579 and form FDA 2877.

Reporting and Recordkeeping for Electronic Products—General Requirements.0910–0025 

800, 801, and 809 ................................................................... Labeling ................................................................................... 0910–0485 

812 ........................................................................................... Investigational Device Exemption ........................................... 0910–0078 

‘‘Allegations of Regulatory Misconduct’’ form .......................... Voluntary Allegations of Regulatory Misconduct .................... 0910–0769 

Dated: September 25, 2024. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2024–22332 Filed 9–27–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket Nos. FDA–2024–N–0758, FDA– 

2024–N–2032, FDA–2023–N–3847, and FDA– 

2024–N–1201] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approvals 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is publishing a 

list of information collections that have 

been approved by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Amber Sanford, Office of Operations, 

Food and Drug Administration, Three 

White Flint North, 10A–12M, 11601 

Landsdown St., North Bethesda, MD 

20852, 301–796–8867, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

following is a list of FDA information 

collections recently approved by OMB 

under section 3507 of the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3507). 

The OMB control number and 

expiration date of OMB approval for 

each information collection are shown 

in table 1. Copies of the supporting 

statements for the information 

collections are available on the internet 

at https://www.reginfo.gov/public/do/ 

PRAMain. An Agency may not conduct 

or sponsor, and a person is not required 

to respond to, a collection of 

information unless it displays a 

currently valid OMB control number. 

TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB 

Title of collection OMB control No. Date approval 

expires 

New Plant Varieties Intended for Food Use ................................................................................................ 0910–0583 9/30/2027 

Food and Cosmetic Export Certificates ....................................................................................................... 0910–0793 9/30/2027 

Biological Products; General Records and Postmarket Adverse Experience Reporting ............................ 0910–0308 9/30/2027

Voluntary Total Product Life Cycle Advisory Program Pilot ........................................................................ 0910–0930 9/30/2027 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 189 / Monday, September 30, 2024 / Notices 79627 

Dated: September 24, 2024. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2024–22291 Filed 9–27–24; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Recharter for the Council on Graduate 

Medical Education 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Department of Health and Human 

Services is hereby giving notice that the 

Council on Graduate Medical Education 

(COGME or Council) is rechartered. 

DATES: The effective date of the renewed 

charter is September 30, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Shane Rogers, Designated Federal 

Official (DFO), Division of Medicine 

and Dentistry, Bureau of Health 

Workforce, HRSA, 5600 Fishers Lane, 

Room 15N142, Rockville, Maryland 

20857; 301–443–5260; or srogers@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: COGME 

makes recommendations to the 

Secretary of Health and Human Services 

and Congress on matters specified by 

section 762 of the Public Health Service 

Act. Issues addressed by COGME 

include: (1) the supply and distribution 

of physicians in the United States; (2) 

current and future shortages or excesses 

of physicians in medical and surgical 

specialties and subspecialties; (3) issues 

relating to internationalmedical school 

graduates; (4) appropriate federal 

policies with respect to the matters 

specified in (1), (2), and (3) above, 

including policies concerning changes 

in the financing of undergraduate and 

graduate medical education programs 

and changes in the types of medical 

education training in graduate medical 

education programs; (5) appropriate 

efforts to be carried out by hospitals, 

schools of medicine, schools of 

osteopathic medicine, and accrediting 

bodies with respect to the matters 

specified in (1), (2), and (3) above, 

including efforts for changes in 

undergraduate and graduate medical 

education programs; and (6) deficiencies 

in, and needs for improvements in, 

existing databases concerning the 

supply and distribution of, and 

postgraduate training programs for, 

physicians in the United States and 

steps that should be taken to eliminate 

those deficiencies. Not later than 

September 30, 2023, and not less than 

every 5 years thereafter, COGME shall 

submit a report on the recommendations 

made by the committee to the Secretary 

of Health and Human Services, and to 

the Committee on Health, Education, 

Labor, and Pensions of the Senate and 

the Committee on Energy and 

Commerce of the House of 

Representatives. Additionally, COGME 

encourages entities providing graduate 

medical education to conduct activities 

to voluntarily achieve the 

recommendations of the Council; 

develops, publishes, and implements 

performance measures; develops and 

publishes guidelines for longitudinal 

evaluations; and recommends 

appropriation levels for certain 

programs under title VII of the Public 

Health Service Act. 

The renewed charter for COGME was 

approved on September 18, 2024. The 

filing date is September 30, 2024. The 

recharter of COGME gives authorization 

for the Council to operate until 

September 30, 2026. 

A copy of the COGME charter is 

available on the COGME website at 

https://www.hrsa.gov/sites/default/files/ 

hrsa/advisory-committees/graduatemedical-edu/cogme-charter.pdf. A copy 

of the charter also can be obtained by 

accessing the FACA database that is 

maintained by the Committee 

Management Secretariat under the 

General Services Administration. The 

website address for the FACA database 

is http://www.facadatabase.gov/. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–22256 Filed 9–27–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Office of AIDS Research 

Advisory Council. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

Name of Committee: Office of AIDS 

Research Advisory Council. 

Date: October 24, 2024. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: Report from the OAR Director; 

Update on the Development of the NIH 

Strategic Plan and Research Priorities for HIV 

Research. 

Place: Office of AIDS Research, Office of 

the Director, NIH, 5601 Fishers Lane, 

Rockville, MD 20852, (Virtual Meeting) 

https://videocast.nih.gov/. 

Contact Person: CAPT Mary Glenshaw, 

Ph.D., M.P.H., OTR/L, Office of AIDS 

Research, Office of the Director, NIH, 5601 

Fishers Lane, Room 2E61, Rockville, MD 

20852, (301) 496–0357, OARACinfo@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.oar.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 24, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–22274 Filed 9–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 


ddrumheller on DSK120RN23PROD with NOTICES1